Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions

被引:16
|
作者
Han, Cuina [1 ,2 ]
Zhao, Fangfei [1 ]
Wan, Chongyang [1 ]
He, Yanfang [1 ]
Chen, Yan [1 ]
机构
[1] North China Univ Sci & Technol, Affiliated Hosp, Dept Obstet & Gynecol, 73 Jianshe Rd, Tangshan 063000, Hebei, Peoples R China
[2] Fourth Hosp Shijiazhuang, Dept Obstet & Gynecol, Shijiazhuang 050000, Hebei, Peoples R China
关键词
cervical lesions; squamous cell carcinoma antigen; metastasis-associated gene 1; high-risk human papillomavirus; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; CANCER; DIAGNOSIS; ANTIGEN; TIME;
D O I
10.3892/ol.2020.11634
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The application of detection technologies for human papillomavirus (HPV) has increased the resection rate for cervical intraepithelial neoplasia and early cervical cancer types. However, a large number of patients still present with advanced cervical cancer upon diagnosis. Therefore, to find a marker for the early diagnosis of cervical cancer, the present study investigated the expression profiles of squamous cell carcinoma antigen (SCCA), tumor metastasis related factor-1 (MTA1), the multiple tumor suppressor gene P16, and the nucleus-associated antigen Ki-67 in cervical lesions, and evaluated the association between the four proteins and the infection of high-risk (HR)-HPV in cervical lesions. The rate of SCCA expression gradually increased with the progression of cervical lesions, but the increase in SCCA expression levels from low-grade squamous intraepithelial lesions (LSIL) to high-grade squamous intraepithelial lesions was not significant (P=0.197). The positive rate of MTA1 expression gradually increased with the development of cervical lesions, but the increase from chronic cervicitis to LSIL was not significant (P=0.258). The positive rates of P16 and Ki-67 expression exhibited significant increasing trends with the progression of cervical lesions. The expression ratio of SCCA between HR-HPV infection and non-infection groups was not statistically significant (P=0.38), but the expression ratios of MTA1, P16 and Ki-67 between HR-HPV infection and non-infection groups were statistically significant (P<0.05). These results demonstrated that the expression of SCCA, MTA1, P16 and Ki-67 increased gradually with the severity of cervical lesions. In addition, there was a positive association between the expression levels of MTA1, P16 and Ki-67 and the infection of HR-HPV in cervical lesions. Therefore, SCCA, MTA1, P16 and Ki-67 may be used to enhance the diagnostic accuracy for cervical lesions.
引用
收藏
页码:884 / 892
页数:9
相关论文
共 50 条
  • [41] The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2
    Miyamoto, Shingo
    Hasegawa, Junichi
    Morioka, Miki
    Hirota, Yuko
    Kushima, Miki
    Sekizawa, Akihiko
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 134 (01) : 45 - 48
  • [42] RE: p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
    Garner, David M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [43] Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias
    Bar, JK
    Harlozinska, A
    Sedlaczek, P
    Kasiak, J
    Markowska, J
    ANTICANCER RESEARCH, 2001, 21 (2A) : 1001 - 1006
  • [44] Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial
    Major, Attila Louis
    Dvorak, Vladimir
    Schwarzova, Jana
    Skrivanek, Ales
    Malik, Tomas
    Pluta, Marek
    Mayboroda, Ivanna
    Grandjean, Etienne Marc
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) : 501 - 511
  • [45] HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
    Lewitowicz, Piotr
    Nasierowska-Guttmejer, Anna
    Rokita, Wojciech
    Adamczyk-Gruszka, Olga
    Gluszek, Stanislaw
    Chrapek, Magdalena
    Kolos, Malgorzata
    Wrona-Cyranowska, Agnieszka
    Misiek, Marcin
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (01) : 87 - 93
  • [46] HPV genotyping and p16/Ki-67 dual staining in the detection of high-grade cervical lesion in patients with LSIL on Pap smear
    Moleriu, Lavinia-Cristina
    Sas, Ioan
    Ratiu, Adrian Claudiu
    Margan, Madalin-Marius
    Secosan, Cristina-Anamaria
    Ilina, Razvan-Stefan
    Horhat, Florin-George
    Stana, Loredana Gabriela
    Grigoras, Dorin
    Pirtea, Laurentiu Cornel
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (02): : 433 - 437
  • [47] Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
    Vega-Pena, Arianna
    Illades-Aguiar, Berenice
    Flores-Alfaro, Eugenia
    Lopez-Bayghen, Esther
    Antonio Leyva-Vazquez, Marco
    Castaneda-Saucedo, Eduardo
    del Carmen Alarcon-Romero, Luz
    JOURNAL OF CYTOLOGY, 2013, 30 (04) : 226 - 232
  • [48] Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women
    Jiang, Ming-Yue
    Wu, Zeni
    Li, Tingyuan
    Yu, Lulu
    Zhang, Shao-Kai
    Zhang, Xun
    Qu, Pengpeng
    Sun, Peisong
    Xi, Ming-Rong
    Liu, Xin
    Liao, Guangdong
    Sun, Lixin
    Zhang, Yongzhen
    Chen, Wen
    Qiao, You-Lin
    CANCER PREVENTION RESEARCH, 2020, 13 (02) : 163 - 171
  • [49] Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA
    Solares, Concepcion
    Velasco, Julio
    Alvarez-Ruiz, Eduardo
    Gonzalez-Fernandez, Laura
    Encinas, Ana-Isabel
    Astudillo, Aurora
    Schneider, Jose
    ANTICANCER RESEARCH, 2015, 35 (11) : 6291 - 6295
  • [50] RE: p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women RESPONSE
    Wentzensen, Nicolas
    Fetterman, Barbara
    Castle, Philip
    Schiffman, Mark
    Wood, Shannon
    Tokugawa, Diane
    Bodelon, Clara
    Poitras, Nancy
    Lorey, Tom
    Kinney, Walter
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):